Report Content
- Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
- Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
- Executive Summary
- Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
- Aptamers Market, By Product
5.1 Introduction
5.2 Instrumentation
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Consumables
5.3.1 Market Overview
5.3.2 Market Size and Forecast
- Aptamers Market, By End-use
6.1 Introduction
6.2 Hospitals & Diagnostics Centers
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Biotechnology & Pharmaceutical Companies
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Others
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Academic & Government Research Institutes
6.5.1 Market Overview
6.5.2 Market Size and Forecast
- Aptamers Market, By Application
7.1 Introduction
7.2 Genomics
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Drug discovery
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Agricultural biotechnology
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 Others
7.5.1 Market Overview
7.5.2 Market Size and Forecast
7.6 Cancer diagnosis and treatment
7.6.1 Market Overview
7.6.2 Market Size and Forecast
7.7 Gene expression
7.7.1 Market Overview
7.7.2 Market Size and Forecast
7.8 Genotyping
7.8.1 Market Overview
7.8.2 Market Size and Forecast
- Aptamers Market, By Type
8.1 Introduction
8.2 RNA-Based Aptamers
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 XNA-Based Aptamers
8.3.1 Market Overview
8.3.2 Market Size and Forecast
8.4 DNA-Based Aptamers
8.4.1 Market Overview
8.4.2 Market Size and Forecast
- Aptamers Market, By Geography
9.1 Introduction
9.2 Europe
9.2.1 Europe Market, By Product
9.2.2 Europe Market, By End-use
9.2.3 Europe Market, By Application
9.2.4 Europe Market, By Type
9.3 North America
9.3.1 North America Market, By Product
9.3.2 North America Market, By End-use
9.3.3 North America Market, By Application
9.3.4 North America Market, By Type
9.4 Asia Pacific
9.4.1 Asia Pacific Market, By Product
9.4.2 Asia Pacific Market, By End-use
9.4.3 Asia Pacific Market, By Application
9.4.4 Asia Pacific Market, By Type
9.5 Rest of The World
9.5.1 Rest of The World Market, By Product
9.5.2 Rest of The World Market, By End-use
9.5.3 Rest of The World Market, By Application
9.5.4 Rest of The World Market, By Type
- Competitive Insights
10.1 Key Insights
10.2 Company Market Share Analysis
10.3 Strategic Outlook
10.3.1 Mergers & Acquisitions
10.3.2 New Product Development
10.3.3 Portfolio/Production Capacity Expansions
10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5 Others
- Company Profiles
11.1 CapitalBio Corporation
11.1.1 Company Overview
11.1.2 Product/Service Landscape
11.1.3 Financial Overview
11.1.4 Recent Developments
11.2 Greiner Bio One International GmbH
11.2.1 Company Overview
11.2.2 Product/Service Landscape
11.2.3 Financial Overview
11.2.4 Recent Developments
11.3 Microarrays Inc
11.3.1 Company Overview
11.3.2 Product/Service Landscape
11.3.3 Financial Overview
11.3.4 Recent Developments
11.4 MYcroarray
11.4.1 Company Overview
11.4.2 Product/Service Landscape
11.4.3 Financial Overview
11.4.4 Recent Developments
11.5 Oxford Gene Technology
11.5.1 Company Overview
11.5.2 Product/Service Landscape
11.5.3 Financial Overview
11.5.4 Recent Developments
11.6 Am Biotechnologies, LLC
11.6.1 Company Overview
11.6.2 Product/Service Landscape
11.6.3 Financial Overview
11.6.4 Recent Developments
11.7 Thermo Fisher Scientific, Inc
11.7.1 Company Overview
&